Nancy F. Goodman

Nancy F. Goodman
Founder and Executive Director
Kids v. Cancer​
Washington, District of Columbia

​Nancy F. Goodman is a leading pediatric cancer advocate and is the founder and executive director of Kids v Cancer, whose mission is to promote pediatric cancer research by identifying structural impediments at key junctures in the research process – new drugs, tissue donation and access to funding – and developing strategies to address them. Through Kids v Cancer, Ms. Goodman successfully authored and championed a federal law, the Creating Hope Act, Section 908 of the FDA Safety and Innovation Act, which creates a market-based incentive to spur pediatric cancer drug development. The Creating Hope Act went into effect on October 1, 2013. Nancy Goodman and Kids v Cancer are now working with the FDA, researchers and drug companies to ensure its full and effective implementation.

In addition, Ms. Goodman is working with the FDA in other policy areas to help strengthen pediatric drug development. She is an active member of the patient representative and consultant program at the FDA. Ms. Goodman has started an autopsy tissue donation program for pediatric brain cancers which has already had significant impact on scientific discoveries. Through Kids v Cancer, she has raised the profile of pediatric cancer issues by having September declared to be National Childhood Cancer Awareness Month for each of the past three years. Ms. Goodman founded Kids v Cancer in 2009 in response to the death of her ten-year-old son, Jacob, from medulloblastoma, a pediatric brain cancer. She received a BA from the University of Pennsylvania, a masters in public policy from Harvard Kennedy School of Government and a J.D. from the University of Chicago Law School.